These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 23907717)
1. Costs of Parkinson's disease in a privately insured population. Johnson SJ; Kaltenboeck A; Diener M; Birnbaum HG; Grubb E; Castelli-Haley J; Siderowf AD Pharmacoeconomics; 2013 Sep; 31(9):799-806. PubMed ID: 23907717 [TBL] [Abstract][Full Text] [Related]
2. Early retirement and income loss in patients with early and advanced Parkinson's disease. Johnson S; Davis M; Kaltenboeck A; Birnbaum H; Grubb E; Tarrants M; Siderowf A Appl Health Econ Health Policy; 2011 Nov; 9(6):367-76. PubMed ID: 21919541 [TBL] [Abstract][Full Text] [Related]
3. Direct and indirect costs of non-vertebral fracture patients with osteoporosis in the US. Pike C; Birnbaum HG; Schiller M; Sharma H; Burge R; Edgell ET Pharmacoeconomics; 2010; 28(5):395-409. PubMed ID: 20402541 [TBL] [Abstract][Full Text] [Related]
4. Direct costs and survival of medicare beneficiaries with early and advanced Parkinson's disease. Kaltenboeck A; Johnson SJ; Davis MR; Birnbaum HG; Carroll CA; Tarrants ML; Siderowf AD Parkinsonism Relat Disord; 2012 May; 18(4):321-6. PubMed ID: 22177623 [TBL] [Abstract][Full Text] [Related]
5. Economic burden of epilepsy among the privately insured in the US. Ivanova JI; Birnbaum HG; Kidolezi Y; Qiu Y; Mallett D; Caleo S Pharmacoeconomics; 2010; 28(8):675-85. PubMed ID: 20623993 [TBL] [Abstract][Full Text] [Related]
6. Excess costs associated with patients with chronic thromboembolic pulmonary hypertension in a US privately insured population. Kirson NY; Birnbaum HG; Ivanova JI; Waldman T; Joish V; Williamson T Appl Health Econ Health Policy; 2011 Nov; 9(6):377-87. PubMed ID: 21888449 [TBL] [Abstract][Full Text] [Related]
7. Excess costs associated with patients with pulmonary arterial hypertension in a US privately insured population. Kirson NY; Birnbaum HG; Ivanova JI; Waldman T; Joish V; Williamson T Appl Health Econ Health Policy; 2011 Sep; 9(5):293-303. PubMed ID: 21875160 [TBL] [Abstract][Full Text] [Related]
8. The long-term direct and indirect economic burden among Parkinson's disease caregivers in the United States. Martinez-Martin P; Macaulay D; Jalundhwala YJ; Mu F; Ohashi E; Marshall T; Sail K Mov Disord; 2019 Feb; 34(2):236-245. PubMed ID: 30589953 [TBL] [Abstract][Full Text] [Related]
9. Economic Burden of Irritable Bowel Syndrome with Diarrhea: Retrospective Analysis of a U.S. Commercially Insured Population. Buono JL; Mathur K; Averitt AJ; Andrae DA J Manag Care Spec Pharm; 2017 Apr; 23(4):453-460. PubMed ID: 28345443 [TBL] [Abstract][Full Text] [Related]
10. Direct and indirect healthcare resource utilization and costs associated with ulcerative colitis in a privately-insured employed population in the US. Cohen R; Skup M; Ozbay AB; Rizzo J; Yang M; Diener M; Chao J J Med Econ; 2015 Jun; 18(6):447-56. PubMed ID: 25728698 [TBL] [Abstract][Full Text] [Related]
11. Economic burden of irritable bowel syndrome with constipation: a retrospective analysis of health care costs in a commercially insured population. Doshi JA; Cai Q; Buono JL; Spalding WM; Sarocco P; Tan H; Stephenson JJ; Carson RT J Manag Care Spec Pharm; 2014 Apr; 20(4):382-90. PubMed ID: 24684643 [TBL] [Abstract][Full Text] [Related]
12. The cost of disability and medically related absenteeism among employees with multiple sclerosis in the US. Ivanova JI; Birnbaum HG; Samuels S; Davis M; Phillips AL; Meletiche D Pharmacoeconomics; 2009; 27(8):681-91. PubMed ID: 19712010 [TBL] [Abstract][Full Text] [Related]
13. Costs of illness in a Russian cohort of patients with Parkinson's disease. Winter Y; von Campenhausen S; Popov G; Reese JP; Klotsche J; Bötzel K; Gusev E; Oertel WH; Dodel R; Guekht A Pharmacoeconomics; 2009; 27(7):571-84. PubMed ID: 19663528 [TBL] [Abstract][Full Text] [Related]
14. Economic Burden of Illness Among Commercially Insured Patients with Systemic Sclerosis with Interstitial Lung Disease in the USA: A Claims Data Analysis. Zhou Z; Fan Y; Thomason D; Tang W; Liu X; Zhou ZY; Macaulay D; Fischer A Adv Ther; 2019 May; 36(5):1100-1113. PubMed ID: 30929184 [TBL] [Abstract][Full Text] [Related]
15. Burden of illness in patients with possible Lennox-Gastaut syndrome: A retrospective claims-based study. Reaven NL; Funk SE; Montouris GD; Saurer TB; Story TJ Epilepsy Behav; 2018 Nov; 88():66-73. PubMed ID: 30241056 [TBL] [Abstract][Full Text] [Related]
16. Costs of illness and care in Parkinson's disease: an evaluation in six countries. von Campenhausen S; Winter Y; Rodrigues e Silva A; Sampaio C; Ruzicka E; Barone P; Poewe W; Guekht A; Mateus C; Pfeiffer KP; Berger K; Skoupa J; Bötzel K; Geiger-Gritsch S; Siebert U; Balzer-Geldsetzer M; Oertel WH; Dodel R; Reese JP Eur Neuropsychopharmacol; 2011 Feb; 21(2):180-91. PubMed ID: 20888737 [TBL] [Abstract][Full Text] [Related]
17. Clinical and Economic Burden of Commercially Insured Patients with Acromegaly in the United States: A Retrospective Analysis. Placzek H; Xu Y; Mu Y; Begelman SM; Fisher M J Manag Care Spec Pharm; 2015 Dec; 21(12):1106-12. PubMed ID: 26679960 [TBL] [Abstract][Full Text] [Related]
18. Health Care Costs of Anal Cancer in a Commercially Insured Population in the United States. Wu CF; Xu L; Fu S; Peng HL; Messick CA; Lairson DR J Manag Care Spec Pharm; 2018 Nov; 24(11):1156-1164. PubMed ID: 30362917 [TBL] [Abstract][Full Text] [Related]
19. Direct and indirect costs associated with epileptic partial onset seizures among the privately insured in the United States. Ivanova JI; Birnbaum HG; Kidolezi Y; Qiu Y; Mallett D; Caleo S Epilepsia; 2010 May; 51(5):838-44. PubMed ID: 20002150 [TBL] [Abstract][Full Text] [Related]
20. Societal burden of cluster headache in the United States: a descriptive economic analysis. Ford JH; Nero D; Kim G; Chu BC; Fowler R; Ahl J; Martinez JM J Med Econ; 2018 Jan; 21(1):107-111. PubMed ID: 29125368 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]